Clinical Trial: Risk Scoring Systems in Upper GI-haemorrhage

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Risk Scoring Systems in Upper GI-haemorrhage

Brief Summary: Use of risk scoring systems in the assessment of patients presenting with upper gastrointestinal haemorrhage is increasing. Comparative studies have intended to identify the system of choice, but the majority of these are characterized by retrospective designs, small sample sizes, low rate of severe bleeding, or low mortality. The main aim of this study was to identify the optimal scoring system.

Detailed Summary:
Sponsor: Odense University Hospital

Current Primary Outcome: Need for hospital-based intervention [ Time Frame: 1 month ]

Need of hospital-based intervention was defined as treatment with blood transfusion, endoscopic therapy, transcatheter arterial embolization (TAE), surgery, or identification of cancer at upper endoscopy.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Identification of low-risk patients [ Time Frame: 1 month ]
    Low-risk patients were defined as patients who did not need hospital-based intervention, and survived more than 30 days from day of admission. Low-risk patients were considered as suitable for early discharge and potential outpatient management.
  • Rebleeding [ Time Frame: 1 month ]
    Rebleeding was defined as presence of hematemesis, blood per nasogastric tube, or melaena associated with a decline in B-hemoglobin of at least 1mmol/l (not explained by hemodilution) or decline in systolic arterial pressure of at least 20mmHg after the initial bleeding had stopped.
  • 30 day mortality [ Time Frame: 30 days ]


Original Secondary Outcome: Same as current

Information By: Odense University Hospital

Dates:
Date Received: April 27, 2012
Date Started: August 2009
Date Completion:
Last Updated: April 30, 2012
Last Verified: April 2012